145 related articles for article (PubMed ID: 37127942)
21. Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
Sharma A; Rastogi N; Chatterjee G; Kapoor R; Nivargi S; Yadav SP
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1033-e1036. PubMed ID: 33306606
[TBL] [Abstract][Full Text] [Related]
22. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
Front Immunol; 2018; 9():1841. PubMed ID: 30154788
[TBL] [Abstract][Full Text] [Related]
23. [Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].
Ai H; Yin QS; Wang Q; Fu YW; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):239-244. PubMed ID: 32311895
[No Abstract] [Full Text] [Related]
24. Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.
Lang P; Feuchtinger T; Teltschik HM; Schwinger W; Schlegel P; Pfeiffer M; Schumm M; Lang AM; Lang B; Schwarze CP; Ebinger M; Urban C; Handgretinger R
Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S6-10. PubMed ID: 26039210
[TBL] [Abstract][Full Text] [Related]
25. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
Federmann B; Bornhauser M; Meisner C; Kordelas L; Beelen DW; Stuhler G; Stelljes M; Schwerdtfeger R; Christopeit M; Behre G; Faul C; Vogel W; Schumm M; Handgretinger R; Kanz L; Bethge WA
Haematologica; 2012 Oct; 97(10):1523-31. PubMed ID: 22491731
[TBL] [Abstract][Full Text] [Related]
26. TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia.
Maschan M; Shelikhova L; Ilushina M; Kurnikova E; Boyakova E; Balashov D; Persiantseva M; Skvortsova Y; Laberko A; Muzalevskii Y; Kazachenok A; Glushkova S; Bobrynina V; Kalinina V; Olshanskaya Y; Baidildina D; Novichkova G; Maschan A
Bone Marrow Transplant; 2016 May; 51(5):668-74. PubMed ID: 26808573
[TBL] [Abstract][Full Text] [Related]
27. Co-transplantation of mesenchymal stromal cell and haploidentical hematopoietic stem cell with TCR αβ depletion in children with primary immunodeficiency syndromes.
Atay D; Akcay A; Akinci B; Yenigurbuz FD; Ovali E; Ozturk G
Pediatr Transplant; 2021 Dec; 25(8):e14120. PubMed ID: 34409718
[TBL] [Abstract][Full Text] [Related]
28. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
[TBL] [Abstract][Full Text] [Related]
29. Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantation.
Wiebking V; Lee CM; Mostrel N; Lahiri P; Bak R; Bao G; Roncarolo MG; Bertaina A; Porteus MH
Haematologica; 2021 Mar; 106(3):847-858. PubMed ID: 32241852
[TBL] [Abstract][Full Text] [Related]
30. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A
Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924
[TBL] [Abstract][Full Text] [Related]
31. TCR α
Mitchell R; Cole T; Shaw PJ; Mechinaud F; O'Brien T; Fraser C
Pediatr Transplant; 2019 Sep; 23(6):e13517. PubMed ID: 31271477
[TBL] [Abstract][Full Text] [Related]
32. Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.
Locatelli F; Merli P; Pagliara D; Li Pira G; Falco M; Pende D; Rondelli R; Lucarelli B; Brescia LP; Masetti R; Milano GM; Bertaina V; Algeri M; Pinto RM; Strocchio L; Meazza R; Grapulin L; Handgretinger R; Moretta A; Bertaina A; Moretta L
Blood; 2017 Aug; 130(5):677-685. PubMed ID: 28588018
[TBL] [Abstract][Full Text] [Related]
33. [Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report].
Kolgaeva EI; Vasilyeva VA; Kuzmina LA; Drokov MY; Dovydenko MV; Konova ZV; Chebotarev DI; Kovrigina AM; Kamelskih DV; Gaponova TV; Sokolova MA; Subortseva IN; Melikyan AL; Maschan MA; Parovichnikova EN; Savchenko VG
Ter Arkh; 2021 Jul; 93(7):805-810. PubMed ID: 36286732
[TBL] [Abstract][Full Text] [Related]
34. Use of TCR α
Brettig T; Smart J; Choo S; Mechinaud F; Mitchell R; Raj TS; Cole T
J Clin Immunol; 2019 Jul; 39(5):505-511. PubMed ID: 31172381
[TBL] [Abstract][Full Text] [Related]
35. TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data.
Sahasrabudhe K; Otto M; Hematti P; Kenkre V
Leuk Lymphoma; 2019 Mar; 60(3):598-609. PubMed ID: 30187806
[TBL] [Abstract][Full Text] [Related]
36. Donor-derived CAR-T Cells Serve as a Reduced-intensity Conditioning Regimen for Haploidentical Stem Cell Transplantation in Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.
Zhang C; Kong PY; Li S; Chen T; Ni X; Li Y; Wang M; Liu Y; Gao L; Gao L; Peng XG; Sun AH; Wang P; Yang Z; Zhang X; Qian C
J Immunother; 2018; 41(6):306-311. PubMed ID: 29864079
[TBL] [Abstract][Full Text] [Related]
37. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
[TBL] [Abstract][Full Text] [Related]
38. HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders.
Bertaina A; Merli P; Rutella S; Pagliara D; Bernardo ME; Masetti R; Pende D; Falco M; Handgretinger R; Moretta F; Lucarelli B; Brescia LP; Li Pira G; Testi M; Cancrini C; Kabbara N; Carsetti R; Finocchi A; Moretta A; Moretta L; Locatelli F
Blood; 2014 Jul; 124(5):822-6. PubMed ID: 24869942
[TBL] [Abstract][Full Text] [Related]
39. Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.
Locatelli F; Bauquet A; Palumbo G; Moretta F; Bertaina A
Immunol Lett; 2013; 155(1-2):21-3. PubMed ID: 24091162
[TBL] [Abstract][Full Text] [Related]
40. TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.
Merli P; Algeri M; Galaverna F; Bertaina V; Lucarelli B; Boccieri E; Becilli M; Quagliarella F; Rosignoli C; Biagini S; Girolami E; Meschini A; Del Principe G; Sborgia R; Catanoso ML; Carta R; Strocchio L; Pinto RM; Buldini B; Falco M; Meazza R; Pende D; Andreani M; Li Pira G; Pagliara D; Locatelli F
Blood; 2024 Jan; 143(3):279-289. PubMed ID: 37738655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
